| Trial Identifier: | D8530C00007 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT04818632 |
| Start Date: | November 2021 |
| Primary Completion Date: | September 2023 |
| Study Completion Date: | September 2023 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Simplified Chinese (China) Translation |
| Country | Location |
|---|---|
| CN | Beijing, CN, 100142 |
| CN | Chengdu, CN, 610041 |
| CN | Nanjing, CN, 210029 |
| CN | Shanghai, CN, 200032 |
| CN | Wuhan, CN, 430022 |
| CN | Zhengzhou, CN, 450008 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company